Białostockie Centrum Onkologii im. Marii Skłodowskiej-Curie w Białymstoku

Bialystok 15-027

1 studies enrolling now · 2 studies all time

What they study most

Metastatic HER2-positive Breast Cancer, Platinum-resistant Ovarian Cancer

Studies at this site

• A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer — Recruiting now
• Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer — Running, not enrolling